Literature DB >> 27563559

Factors associated with patients in the Scottish Highlands who chose mastectomy when suitable for breast conservation.

Rosalyn Shearer1, Majid Rashid1, Gill Hubbard2, Nick Abbott1, Ian Daltrey1, Russell Mullen1.   

Abstract

BACKGROUND: Despite being suitable for breast conservation surgery (BCS) a proportion of women choose mastectomy. This study aimed to assess the pre-operative pathological and geographic factors associated with choosing mastectomy rather than BCS in a single centre that serves a large geographical area encompassing urban, rural and remote island populations.
METHODS: A retrospective analysis of all patients suitable for BCS between January 2011 and December 2013 was undertaken. Pre-operative pathological features were compared using the Pearson chi squared test as was distance to the treatment centre from the patient's home. A questionnaire was sent to all those who chose mastectomy to identify the factors that influenced their decision.
RESULTS: A total of 446 patients suitable for BCS were identified of which 46 (11%) chose to undergo mastectomy. Patients choosing mastectomy were more likely to present symptomatically (P=0.009), have tumours larger than 20 mm at diagnostic imaging (P=0.001) and have positive axillary staging (P=0.004). Patients choosing mastectomy were more likely to live remotely (P=0.051). Those patients who chose mastectomy felt this gave a better long-term outcome (18 patients, 44%) and peace of mind (14 patients, 34%).
CONCLUSIONS: Adverse pre-operative pathological features were associated with patients choosing mastectomy rather than BCS. There was a trend for patients who chose mastectomy to live remotely from the treatment centre. Patients choosing mastectomy most commonly cited a better long-term outcome and peace of mind as the reason behind their decision. Understanding what influences a patient's surgical choice will allow clinicians and patients to engage in a fully informed pre-operative decision making process.

Entities:  

Keywords:  Breast cancer; breast-conserving surgery; choice behaviour; mastectomy

Year:  2016        PMID: 27563559      PMCID: PMC4971352          DOI: 10.21037/gs.2016.03.02

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  22 in total

1.  MSJAMA. Relationship between travel distance and utilization of breast cancer treatment in rural northern Michigan.

Authors:  Terry Meden; Celeste St John-Larkin; Deborah Hermes; Stephen Sommerschield
Journal:  JAMA       Date:  2002-01-02       Impact factor: 56.272

2.  Increasing use of elective mastectomy and contralateral prophylactic surgery among breast conservation candidates: a 14-year report from a comprehensive cancer center.

Authors:  Anthony E Dragun; Jianmin Pan; Elizabeth C Riley; Barbara Kruse; Mary R Wilson; Shesh Rai; Dharamvir Jain
Journal:  Am J Clin Oncol       Date:  2013-08       Impact factor: 2.339

3.  Provider perspectives on presenting risk information and managing worry about recurrence among breast cancer survivors.

Authors:  Nancy K Janz; Rebecca L Leinberger; Brian J Zikmund-Fisher; Sarah T Hawley; Kent Griffith; Reshma Jagsi
Journal:  Psychooncology       Date:  2014-07-23       Impact factor: 3.894

4.  Impact of patient distance to radiation therapy on mastectomy use in early-stage breast cancer patients.

Authors:  Anneke T Schroen; David R Brenin; Maria D Kelly; William A Knaus; Craig L Slingluff
Journal:  J Clin Oncol       Date:  2005-10-01       Impact factor: 44.544

5.  Which eligible breast conservation patients choose mastectomy in the setting of newly diagnosed breast cancer?

Authors:  Cameron D Adkisson; Sanjay P Bagaria; Alexander S Parker; Jillian M Bray; Tammeza Gibson; Colleen S Thomas; Michael G Heckman; Sarah A McLaughlin
Journal:  Ann Surg Oncol       Date:  2012-04       Impact factor: 5.344

6.  Predictors of Mastectomy for Women with Breast Cancer in the Greater Western Region of Sydney.

Authors:  Richard Taylor; Joanne M. Stubbs; Allan O. Langlands; John Boyages
Journal:  Breast J       Date:  1999-03       Impact factor: 2.431

7.  Disparities in urban and rural mastectomy populations : the effects of patient- and county-level factors on likelihood of receipt of mastectomy.

Authors:  Lisa K Jacobs; Katherine A Kelley; Gedge D Rosson; Meagan E Detrani; David C Chang
Journal:  Ann Surg Oncol       Date:  2008-07-29       Impact factor: 5.344

8.  Factors predictive of treatment by Australian breast surgeons of invasive female breast cancer by mastectomy rather than breast conserving surgery.

Authors:  David Roder; Helen Zorbas; James Kollias; Chris Pyke; David Walters; Ian Campbell; Corey Taylor; Fleur Webster
Journal:  Asian Pac J Cancer Prev       Date:  2013

9.  Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

Authors:  Bernard Fisher; Stewart Anderson; John Bryant; Richard G Margolese; Melvin Deutsch; Edwin R Fisher; Jong-Hyeon Jeong; Norman Wolmark
Journal:  N Engl J Med       Date:  2002-10-17       Impact factor: 91.245

10.  Patient choice significantly affects mastectomy rates in the treatment of breast cancer.

Authors:  Robert M Kirby; Abdul Basit; Natarajan Manimaran
Journal:  Int Semin Surg Oncol       Date:  2008-08-11
View more
  3 in total

1.  Surgical treatment choices for breast cancer in Newfoundland and Labrador: a retrospective cohort study.

Authors:  Farah McCrate; Elizabeth Dicks; Erin Powell; Joanne Chafe; Rebecca Roome; Charlene Simmonds; Holly Etchegary
Journal:  Can J Surg       Date:  2018-12-01       Impact factor: 2.089

2.  Factors influencing surgical treatment decisions for breast cancer: a qualitative exploration of surgeon and patient perspectives.

Authors:  E Dicks; R Roome; J Chafe; E Powell; F McCrate; C Simmonds; H Etchegary
Journal:  Curr Oncol       Date:  2019-04-01       Impact factor: 3.677

3.  Trends in surgery and adjuvant treatment for early-stage breast cancer: a population-based study in Queensland, Australia.

Authors:  Philippa Youl; Shoni Philpot; Julie Moore; Michelle Morris; David E Theile
Journal:  Breast Cancer Res Treat       Date:  2022-03-07       Impact factor: 4.872

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.